Intellia Therapeutics Inc (NASDAQ:NTLA)

53.96
Delayed Data
As of Sep 23
 -3.12 / -5.47%
Today’s Change
37.08
Today|||52-Week Range
155.63
-54.36%
Year-to-Date

Stock Price Forecast

The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 123.50, with a high estimate of 207.00 and a low estimate of 50.00. The median estimate represents a +128.87% increase from the last price of 53.96.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Intellia Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.29
Sales
$11.6M
Reporting Date
Nov 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 2.69%
 
 
 
 
 
 
Growthannually -55.23%
 
 
 
 
 
 

Sales

Growthquarterly -17.56%
 
 
 
 
 
 
Growthannually 52.00%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.